Skip to main content

Table 4 One year follow-up and outcome data for the studied group of ten living-related renal transplant recipients

From: The feasibility and applications of non-invasive cardiac output monitoring, thromboelastography and transit-time flow measurement in living-related renal transplantation surgery: results of a prospective pilot observational study

Patient

DGF

Thromboembolic graft complication

VTE

Haemorrhagic graft complication

Rejection

Treatment for rejection

Creatinine 6 months

Creatinine 1 year

Dialysis (at 1 yr)

  

Yes/No

Type

 

Yes/No

Type

Yes/No

Type

    

P1 a

✗

No

 

✗

Yes

Large perigraft haematoma

Yes

Early acute rejection.

bATG for early rejection; successful

115

286

Yes

Chronic antibody mediated rejection from 9 months

eCampath, no benefit

P2

✗

No

 

✗

No

 

No

  

120

111

No

P3

✗

Yes

Intra-operative transplant artery thrombosis - surgically corrected

✗

No

 

No

  

84

87

No

P4

✗

No

 

✗

No

 

No

  

67

79

No

P5

✓

  

✗

  

Yes

Antibody mediated acute rejection cause of cDGF

Early short term dialysis. ATG, Methylprednisolone, dMMF; successful

104

130

No

P6

✗

No

 

✗

No

 

Yes

Acute early rejection

ATG; successful

134

101

No

P7

✗

No

 

✗

No

 

Yes

Early antibody mediated rejection

Pulsed oral prednisolone regimen; successful

144

123

No

P8

✗

No

 

✗

No

 

No

  

129

129

No

P9

✗

No

 

✗

No

 

Yes

Early antibody mediated rejection

Pulsed oral prednisolone regimen; successful

103

114

No

P10

✗

  

✗

No

 

No

   

132

No

  1. aPatient (P) 1 demonstrated graft failure within 1-year as defined by a return to dialysis-dependent status. bATG, anti-thymocyte globulin; cDGF, delayed graft function; dMMF, mycophenolate mofetil; eCampath, Alemtuzumab.